SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Stabilisation Notice

27 Sep 2013 13:28

RNS Number : 1313P
Merrill Lynch Intl (DTG) Syndicate
27 September 2013
Β 

ο»Ώ

Β 

PRE-STABILISATION ANNOUNCEMENT

Β 

27 September 2013

Merrill Lynch Intl Syndicate

Β 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Β 

Rentokil Initial Plc

Stabilisation Notice

Β 

Merrill Lynch International (contact: Carina Powolozky telephone: 0044 207 9953966) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

Β 

The securities:

Issuer:

Rentokil Initial Plc

Guarantor (if any):

Rentokil Initial 1927 Plc

Aggregate nominal amount:

EUR 350,000,000

Description:

Senior unsecured notes

Other offer terms:

Stabilisation:

Stabilisation Manager(s):

Merrill Lynch International (Stabilisation Coordinator)Barclays Bank Plc

BNP Paribas

Mizuho International Plc

Stabilisation period expected to start on:

27 September 2013

Stabilisation period expected to end no later than:

27 October 2013 (30 days after the proposed issue date of the securities)

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilisation Manager(s) may over-allot the securities to the extent permitted in accordance with applicable law.

Β 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

Β 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

Β 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

Β 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

Β 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STAPGUPPBUPWGPM
Date   Source Headline
19th Jul 20177:00 amRNSAppointment of Non-Executive Director
30th Jun 20178:33 amRNSCompletion of Joint Venture with Haniel
27th Jun 20175:21 pmRNSHolding(s) in Company
26th Jun 20174:54 pmRNSHolding(s) in Company
8th Jun 201711:40 amRNSFurther re Joint Venture with Haniel
7th Jun 20179:41 amRNSDirector Declaration
17th May 20175:02 pmRNSHolding(s) in Company
10th May 20174:31 pmRNSResult of AGM
10th May 20174:03 pmRNSHolding(s) in Company
10th May 201711:49 amRNSAppointment of Senior Independent Director
9th May 20175:51 pmRNSHolding(s) in Company
4th May 20174:44 pmRNSDirector/PDMR Shareholding
26th Apr 20174:27 pmRNSDirector/PDMR Shareholding
25th Apr 20175:58 pmRNSDirector/PDMR Shareholding
21st Apr 20177:00 amRNSRentokil awarded Queen's Award for Enterprise
19th Apr 20177:00 amRNSQ1 Trading Update
5th Apr 201710:43 amRNSAnnual Financial Report
31st Mar 20174:18 pmRNSTotal Voting Rights
30th Mar 20173:25 pmRNSBlock listing Interim Review
22nd Mar 20176:10 pmRNSHolding(s) in Company
9th Mar 20173:06 pmRNSAdditional Listing
28th Feb 20177:00 amRNSRentokil - Leading Pest Control Company in India
24th Feb 20172:37 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSFinal Results
7th Feb 20177:00 amRNSAcquisition of Allgood Pest Solutions
29th Dec 20164:30 pmRNSDirector/PDMR Shareholding
16th Dec 20162:59 pmRNSHolding(s) in Company
16th Dec 20162:02 pmRNSHolding(s) in Company
16th Dec 20167:00 amRNSJoint venture with Haniel
7th Dec 20165:47 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSHolding(s) in Company
18th Nov 20161:15 pmRNSDirector Declaration
11th Nov 20165:30 pmRNSHolding(s) in Company
11th Nov 20165:10 pmRNSTotal Voting Rights
3rd Nov 20161:01 pmRNSDirector Declaration
19th Oct 20167:00 amRNSQ3 Trading Update
6th Oct 20162:58 pmRNSAdditional Listing
6th Oct 201612:31 pmRNSDirector Declaration
4th Oct 20169:49 amRNSDirector Declaration
30th Sep 20162:10 pmRNSTotal Voting Rights
29th Sep 20167:00 amRNSAdditional Listing
26th Sep 20164:48 pmRNSDirector/PDMR Shareholding
22nd Aug 20164:56 pmRNSHolding(s) in Company
28th Jul 20167:00 amRNSHalf Yearly Report
27th Jul 20167:00 amRNSCollaboration with Google and PA Consulting Group
7th Jul 20167:00 amRNSAcquisition, CDC Contract Win and Trading Update
29th Jun 20167:00 amRNSDirectorate Change
29th Jun 20167:00 amRNSDirector/PDMR Shareholding
22nd Jun 20165:27 pmRNSHolding(s) in Company
17th May 20165:06 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.